Orexo AB Valuation
| ORXOY Stock | USD 1.00 0.02 2.04% |
Today, the company appears to be overvalued. Orexo AB ADR holds a recent Real Value of $0.93 per share. The prevailing price of the company is $1.0. Our model determines the value of Orexo AB ADR from analyzing the company fundamentals such as Current Valuation of 76.98 M, price to earning of 17.22 X, and Return On Equity of -0.65 as well as examining its technical indicators and probability of bankruptcy. . In general, most investors support acquiring undervalued entities and dropping overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Orexo AB's price fluctuation is abnormally volatile at this time. Calculation of the real value of Orexo AB ADR is based on 3 months time horizon. Increasing Orexo AB's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Orexo otc stock is determined by what a typical buyer is willing to pay for full or partial control of Orexo AB ADR. Since Orexo AB is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Orexo OTC Stock. However, Orexo AB's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0 | Real 0.93 | Hype 1.0 | Naive 1.07 |
The intrinsic value of Orexo AB's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Orexo AB's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Orexo AB ADR helps investors to forecast how Orexo otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Orexo AB more accurately as focusing exclusively on Orexo AB's fundamentals will not take into account other important factors: Orexo AB Total Value Analysis
Orexo AB ADR is now estimated to have takeover price of 76.98 M with market capitalization of 58.73 M, debt of 492.3 M, and cash on hands of 58.17 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Orexo AB fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
76.98 M | 58.73 M | 492.3 M | 58.17 M |
Orexo AB Investor Information
The book value of the company was now reported as 1.38. The company had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Orexo AB's historical financial statements, Orexo AB ADR is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Orexo AB Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Orexo AB has an asset utilization ratio of 44.36 percent. This suggests that the OTC Stock is making $0.44 for each dollar of assets. An increasing asset utilization means that Orexo AB ADR is more efficient with each dollar of assets it utilizes for everyday operations.Orexo AB Profitability Analysis
The company reported the revenue of 565 M. Net Loss for the year was (223.5 M) with profit before overhead, payroll, taxes, and interest of 521.7 M.About Orexo AB Valuation
Our relative valuation model uses a comparative analysis of Orexo AB. We calculate exposure to Orexo AB's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Orexo AB's related companies.Orexo AB , a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Orexo AB was incorporated in 1994 and is headquartered in Uppsala, Sweden. OREXO AB is traded on OTC Exchange in the United States.
8 Steps to conduct Orexo AB's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Orexo AB's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Orexo AB's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Orexo AB's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Orexo AB's revenue streams: Identify Orexo AB's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Orexo AB's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Orexo AB's growth potential: Evaluate Orexo AB's management, business model, and growth potential.
- Determine Orexo AB's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Orexo AB's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Orexo AB Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 34.3 M | |
| Quarterly Earnings Growth Y O Y | 4.85 | |
| Forward Price Earnings | 9.2764 | |
| Retained Earnings | -1.5 B |
Additional Tools for Orexo OTC Stock Analysis
When running Orexo AB's price analysis, check to measure Orexo AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orexo AB is operating at the current time. Most of Orexo AB's value examination focuses on studying past and present price action to predict the probability of Orexo AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orexo AB's price. Additionally, you may evaluate how the addition of Orexo AB to your portfolios can decrease your overall portfolio volatility.